15 Oct 2008 13:33
| For Immediate Release | 15 October 2008 |
ALLIANCE PHARMA PLC
("the Company")
Director Share Purchases
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 15 October 2008 that two directors have made the following purchases of the Company's shares.
Richard Wright, the Company's Finance Director, purchased 100,000 ordinary shares of 1p each in the Company on 15 October 2008 at a price of 4.0p per share. Mr Wright's resultant shareholding is 190,768 ordinary shares, equivalent to 0.12 per cent of the Company's issued share capital.
Andrew Smith, a Non-Executive Director of the Company, purchased 40,000 ordinary shares of 1p each in the Company on 14 October 2008 at a price of 4.0p per share. Mr Smith's resultant shareholding is 200,000 ordinary shares, equivalent to 0.12 per cent of the Company's issued share capital.
For further information:
| Alliance Pharma plc | + 44 (0) 1249 466966 |
| John Dawson, Chief Executive | |
| Richard Wright, Finance Director | |
| www.alliancepharma.co.uk | |
| | |
| Buchanan Communications | + 44 (0) 20 7466 5000 |
| Mark Court / Rebecca Skye Dietrich | |
| | |
| Numis Securities Limited | + 44 (0) 20 7260 1000 |
| Nominated Adviser: Michael Meade / Brent Nabbs | |
| Corporate Broking: David Poutney | |
Alliance Pharma (APH)